CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

RehabPath

RehabPath is a company that helps individuals find addiction and mental health treatment that fits their needs. They provide information on rehab centers, pricing, insurance, reviews, and more.

United Cerebrial Palsy

United Cerebrial Palsy is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Atlantic AllCare

Atlantic AllCare is a Deerfield Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

A-Dec, Inc.

A-Dec, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Newberg, OR. To find more information about A-Dec, Inc., please visit www.a-dec.com

Pacific Island Medical Inc

Pacific Island Medical Inc is a Kailua, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.